scholarly journals Tumor microenvironment characterization in stage IV gastric cancer

2021 ◽  
Vol 41 (1) ◽  
Author(s):  
Xianxue Zhang ◽  
Feng Yang ◽  
Zhenbao Wang
Keyword(s):  
Gene Expression ◽  
Gastric Cancer ◽  
Expression Profiles ◽  
Gene Expression Profiles ◽  
Stage Iv ◽  
Gene Expression Omnibus ◽  
The Cancer Genome Atlas ◽  
Stage Iv Gastric Cancer ◽  
Th 17 ◽  
Cancer Genome Atlas

Abstract Immunotherapy is remarkably affected by the immune environment of the principal tumor. Nonetheless, the immune environment’s clinical relevance in stage IV gastric cancer (GC) is largely unknown. The gene expression profiles of 403 stage IV GC patients in the three cohorts: GEO (Gene Expression Omnibus, GSE84437 (n=292) and GSE62254 (n=77), and TCGA (The Cancer Genome Atlas, n=34) were used in the present study. Using four publicly available stage IV GC expression datasets, 29 immune signatures were expression profiled, and on this basis, we classified stage IV GC. The classification was conducted using the hierarchical clustering method. Three stage IV GC subtypes L, M, and H were identified representing low, medium, and high immunity, respectively. Immune correlation analysis of these three types revealed that Immune H exhibited a better prognostic outcome as well as a higher immune score compared with other subtypes. There was a noticeable difference in the three subgroups of HLA genes. Further, on comparing with other subtypes, CD86, CD80, CD274, CTLA4, PDCD1, and PDCD1LG2 had higher expression in the Immunity H subtype. In stage IV GC, potentially positive associations between immune and pathway activities were displayed, due to the enrichment of pathways including TNF signaling, Th-17 cell differentiation, and JAK-STAT signaling pathways in Immunity H vs Immunity L subtypes. External cohorts from TCGA cohort ratified these results. The identification of stage IV GC subtypes has potential clinical implications in stage IV GC treatment.

Preliminary screening of gastric cancer related transcripts based on nanometric magnetic beads

2020 ◽  
Vol 10 (9) ◽  
pp. 1490-1497
Author(s):  
Diqun Liu ◽  
Wenbo Cao ◽  
Guangsheng Hu ◽  
Nannan Wang ◽  
Weiwei Zhou
Keyword(s):  
Gene Expression ◽  
Gastric Cancer ◽  
Magnetic Beads ◽  
Expression Profiles ◽  
Gastrointestinal Surgery ◽  
Gene Expression Profiles ◽  
Magnetic Bead ◽  
The Cancer Genome Atlas ◽  
Differentially Expressed ◽  
Low Levels

The aim of this study was to use current genomics methodologies to screen for gastric cancer (GC)-related gene expression and to compare expression levels associated with GC and paracancerous tissues. These findings will be considered together with patient clinicopathological data with the goal of identifying new tumor markers and novel directions for diagnosis and treatment. GC-associated gene expression profiles were identified in the Gene Expression Omnibus (GEO) and The Cancer Genome Atlas (TCGA) databases; these resources facilitated identification of genes that were differentially expressed in GC and adjacent normal tissues. Genomics screening identified ∼49 genes that were expressed at comparatively high levels and 65 genes that were expressed at comparatively low levels in association with GC. Moreover, specimens from fifty-six patients diagnosed with GC who underwent gastrointestinal surgery between March 2017 to September 2018 were used to generate RNA that was evaluated by real-time fluorescence quantitative PCR in order to confirm differential expression of genes encoding orosomucoid 1 (ORM1), hepsin (HPN), uridine phosphorylase 1 (UPP1), and glycoprotein nonmetastatic melanoma protein B (GPNMB). The nucleic acid of these samples was extracted by nanometric magnetic bead method. Among our findings, GPNMB was expressed at relatively high levels in association GC, while both ORM1 and HPN are expressed at relatively low levels in these tissues and expression of UPP1 remained unchanged. Taken together, our findings suggest that genomics methodologies can be used to identify differentially expressed genes in a comparison of GC to adjacent paracancerous tissue. Our findings also suggest that the transmembrane glycoprotein GPNMB may play a role in promoting the incidence and development of GC.

scholarly journals Identification of Novel Hub Genes Associated With Gastric Cancer Using Integrated Bioinformatics Analysis

2020 ◽  
Author(s):  
Xiao-Qing Lu ◽  
Jia-qian Zhang ◽  
Jun Qiao ◽  
Sheng-Xiao Zhang ◽  
Meng-Ting Qiu ◽  
...  
Keyword(s):  
Gene Expression ◽  
Gastric Cancer ◽  
Malignant Tumors ◽  
Expression Profiles ◽  
Gene Expression Profiles ◽  
Gene Expression Omnibus ◽  
High Recurrence Rate ◽  
Hub Genes ◽  
Tissue Samples ◽  
Qrt Pcr

Abstract Background: Gastric cancer (GC) is one of the most common solid malignant tumors worldwide with a high-recurrence-rate. Identifying the molecular signatures and specific biomarkers of GC might provide novel clues for GC prognosis and targeted therapy.Methods: Gene expression profiles were obtained from the ArrayExpress and Gene Expression Omnibus database. Differentially expressed genes (DEGs) were picked out by R software. The hub genes were screened by cytoHubba plugin. Their prognostic values were assessed by Kaplan–Meier survival analyses and the gene expression profiling interactive analysis (GEPIA). Finally, qRT-PCR in GC tissue samples was established to validate these DEGs. Results: Total of 295 DEGs were identified between GC and their corresponding normal adjacent tissue samples in E-MTAB-1440, GSE79973, GSE19826, GSE13911, GSE27342, GSE33335 and GSE56807 datasets, including 117 up-regulated and 178 down-regulated genes. Among them, 7 vital upregulated genes (HMMR, SPP1, FN1, CCNB1, CXCL8, MAD2L1 and CCNA2) were selected. Most of them had a significantly worse prognosis except SPP1. Using qRT-PCR, we validated that their transcriptions in our GC tumor tissue were upregulated except SPP1 and FN1, which correlated with tumor relapse and predicts poorer prognosis in GC patients.Discussion: We have identified 5 upregulated DEGs (HMMR, CCNB1, CXCL8, MAD2L1, and CCNA2) in GC patients with poor prognosis using integrated bioinformatical methods, which could be potential biomarkers and therapeutic targets for GC treatment.

scholarly journals Identification of novel hub genes associated with gastric cancer using integrated bioinformatics analysis

BMC Cancer ◽  
2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Xiao-Qing Lu ◽  
Jia-Qian Zhang ◽  
Sheng-Xiao Zhang ◽  
Jun Qiao ◽  
Meng-Ting Qiu ◽  
...  
Keyword(s):  
Gene Expression ◽  
Gastric Cancer ◽  
Malignant Tumors ◽  
Expression Profiles ◽  
Gene Expression Profiles ◽  
Gene Expression Omnibus ◽  
High Recurrence Rate ◽  
Hub Genes ◽  
Tissue Samples ◽  
Qrt Pcr

Abstract Background Gastric cancer (GC) is one of the most common solid malignant tumors worldwide with a high-recurrence-rate. Identifying the molecular signatures and specific biomarkers of GC might provide novel clues for GC prognosis and targeted therapy. Methods Gene expression profiles were obtained from the ArrayExpress and Gene Expression Omnibus database. Differentially expressed genes (DEGs) were picked out by R software. The hub genes were screened by cytohubba plugin. Their prognostic values were assessed by Kaplan–Meier survival analyses and the gene expression profiling interactive analysis (GEPIA). Finally, qRT-PCR in GC tissue samples was established to validate these DEGs. Results Total of 295 DEGs were identified between GC and their corresponding normal adjacent tissue samples in E-MTAB-1440, GSE79973, GSE19826, GSE13911, GSE27342, GSE33335 and GSE56807 datasets, including 117 up-regulated and 178 down-regulated genes. Among them, 7 vital upregulated genes (HMMR, SPP1, FN1, CCNB1, CXCL8, MAD2L1 and CCNA2) were selected. Most of them had a significantly worse prognosis except SPP1. Using qRT-PCR, we validated that their transcriptions in our GC tumor tissue were upregulated except SPP1 and FN1, which correlated with tumor relapse and predicts poorer prognosis in GC patients. Conclusions We have identified 5 upregulated DEGs (HMMR, CCNB1, CXCL8, MAD2L1, and CCNA2) in GC patients with poor prognosis using integrated bioinformatical methods, which could be potential biomarkers and therapeutic targets for GC treatment.

scholarly journals Cancer gene expression profiles associated with clinical outcomes to chemotherapy treatments

2020 ◽  
Vol 13 (S8) ◽  
Author(s):  
Nicolas Borisov ◽  
Maxim Sorokin ◽  
Victor Tkachev ◽  
Andrew Garazha ◽  
Anton Buzdin
Keyword(s):  
Gene Expression ◽  
Expression Profiles ◽  
Gene Expression Profiles ◽  
Gene Expression Omnibus ◽  
The Cancer Genome Atlas ◽  
Low Grade ◽  
Sequencing Data ◽  
Kidney Tumors ◽  
Pediatric Leukemia ◽  
Adult Leukemia

Abstract Background Machine learning (ML) methods still have limited applicability in personalized oncology due to low numbers of available clinically annotated molecular profiles. This doesn’t allow sufficient training of ML classifiers that could be used for improving molecular diagnostics. Methods We reviewed published datasets of high throughput gene expression profiles corresponding to cancer patients with known responses on chemotherapy treatments. We browsed Gene Expression Omnibus (GEO), The Cancer Genome Atlas (TCGA) and Tumor Alterations Relevant for GEnomics-driven Therapy (TARGET) repositories. Results We identified data collections suitable to build ML models for predicting responses on certain chemotherapeutic schemes. We identified 26 datasets, ranging from 41 till 508 cases per dataset. All the datasets identified were checked for ML applicability and robustness with leave-one-out cross validation. Twenty-three datasets were found suitable for using ML that had balanced numbers of treatment responder and non-responder cases. Conclusions We collected a database of gene expression profiles associated with clinical responses on chemotherapy for 2786 individual cancer cases. Among them seven datasets included RNA sequencing data (for 645 cases) and the others – microarray expression profiles. The cases represented breast cancer, lung cancer, low-grade glioma, endothelial carcinoma, multiple myeloma, adult leukemia, pediatric leukemia and kidney tumors. Chemotherapeutics included taxanes, bortezomib, vincristine, trastuzumab, letrozole, tipifarnib, temozolomide, busulfan and cyclophosphamide.

A prognostic model constructed by CTHRC1 and LRFN4 in Stomach adenocarcinoma by Bioinformatics Analysis

2020 ◽  
Author(s):  
Songling Han ◽  
Wei Zhu ◽  
Qijie Guan ◽  
Zhuoheng Zhong ◽  
Ruoke Zhao ◽  
...  
Keyword(s):  
Gene Expression ◽  
Prognostic Model ◽  
Cox Regression ◽  
Expression Profiles ◽  
Gene Expression Profiles ◽  
Clinical Information ◽  
The Cancer Genome Atlas ◽  
Risk Scores ◽  
Cancer Genome Atlas ◽  
Stomach Adenocarcinoma

Abstract Background Stomach adenocarcinoma (STAD) is the most common histological type of stomach cancer, which causes a considerable number of deaths worldwide. This study specifically aimed to identify potential biomarkers and reveal the underlying molecular mechanisms. Methods Gene expression profiles microarray data were downloaded from the Gene Expression Omnibus (GEO) database. The ‘limma’ R package was used to screen the differentially expressed genes (DEGs) between STAD and matched normal tissues. The Database for Annotation, Visualization, and Integrated Discovery (DAVID) was used for function enrichment analyses of DEGs. The data of STAD cases with both RNA sequencing and clinical information of The Cancer Genome Atlas (TCGA) were obtained from Genomic Data Commons (GDC) data portal. Survival curves were analyzed by the Kaplan-Meier method, univariate Cox regression analysis and multivariate Cox regression were performed using ‘survival’ package. CIBERSORT algorithm used approach to characterize the 22 human immune cell composition. Gene expression profiles microarray data and clinical information were downloaded from GEO database to validate prognostic model. Results Three public datasets including 90 STAD patients and 43 healthy controls were used and 44 genes were differentially expressed in all three datasets. These genes were primarily implicated in biological processes including cell adhesion, wound healing and extracellular matrix organization. Seven out of 44 genes showed significant survival differences based on their expression differences. CTHRC1 and LRFN4 were eventually used to constructed risk score and prognostic model by univariate Cox regression and stepwise multivariate Cox regression in The Cancer Genome Atlas (TCGA)-STAD dataset. The group having high risk scores and the group having low risk scores had significant differences in the infiltration level of multiple immune cells including CD4 memory resting T cells, M2 macrophages, memory B cells, resting dendritic cells, eosinophils, and gamma delta T cells. Multivariate Cox regression analyses indicated that the risk score was an independent predictor after adjusting for age, sex, and tumor stage. At last, the model was verified and evaluated by another independent dataset and showed a good classification effect. Conclusions The present study constructed the prognostic model by expression of CTHRC1 and LRFN4 for the first time via comprehensive bioinformatics analysis, which may provide clinical guidance and potential therapeutic targets for STAD.

scholarly journals Comprehensive analysis of the gene expression profiles in human gastric cancer cell lines

Oncogene ◽  
2002 ◽  
Vol 21 (42) ◽  
pp. 6549-6556 ◽  
Author(s):  
Jiafu Ji ◽  
Xin Chen ◽  
Suet Yi Leung ◽  
Jen-Tsan A Chi ◽  
Kent Man Chu ◽  
...  
Keyword(s):  
Gene Expression ◽  
Gastric Cancer ◽  
Cell Lines ◽  
Cancer Cell ◽  
Gastric Cancer Cell ◽  
Expression Profiles ◽  
Gene Expression Profiles ◽  
Comprehensive Analysis ◽  
Human Gastric Cancer ◽  
Gastric Cancer Cell Lines

Assessment of cancer prevention effect of exercise

2021 ◽  
pp. 1-6
Author(s):  
Reza Vafaee ◽  
Mostafa Rezaei Tavirani ◽  
Sina Rezaei Tavirani ◽  
Mohammadreza Razzaghi
Keyword(s):  
Gene Expression ◽  
Cancer Prevention ◽  
Human Health ◽  
Expression Profiles ◽  
Vastus Lateralis ◽  
Gene Expression Profiles ◽  
Gene Expression Omnibus ◽  
Vastus Lateralis Muscle ◽  
Before And After ◽  
Exercise Training Intervention

There are many documents about benefits of exercise on human health. However, evidences indicate to positive effect of exercise on disease prevention, understanding of many aspects of this mechanism need more investigations. Determination of critical genes which effect human health. GSE156249 including 12 gene expression profiles of healthy individual biopsy from vastus lateralis muscle before and after 12-week combined exercise training intervention were extracted from gene expression omnibus (GEO) database. The significant DEGs were included in interactome unit by Cytoscape software and STRING database. The network was analyzed to find the central nodes subnetwork clusters. The nodes of prominent cluster were assessed via gene ontology by using ClueGO. Number of 8 significant DEGs and 100 first neighbors analyzed via network analysis. The network includes 2 clusters and COL3A1, BGN, and LOX were determined as central DEGs. The critical DEGs were involved in cancer prevention process.

Sign in / Sign up

Export Citation Format

Share Document